Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Bacteria, the oldest forms of life on earth, are remarkably diverse and exist in astounding numbers. Diseases caused by bacteria include some of the most common infections in the world and some of the most important human scourges, past, present, and probably future. At the same time, each of us is colonized by as many bacterial cells as we have human cells in our bodies. In general, this is a peaceful and even productive (symbiotic) relationship, but occasionally even these well-tolerated residents of the human biosphere cause disease.
We are surrounded by and always exposed to bacteria, including those that evolved to live well with us (e.g., Bacteroides species) and those whose evolution has promoted the tendency to cause disease (e.g., Mycobacterium tuberculosis ) and death (e.g., Bacillus anthracis ). In consequence, and not surprisingly, many of the presently recognized infectious diseases are caused by bacteria. It also may be safely predicted that many important illnesses not yet recognized or widespread (“emerging” infectious diseases) will be found to be caused by bacteria, as will some chronic inflammatory diseases of unknown cause and malignancies (see later). Therefore knowledge of pathogenic bacteria, the diseases to which they lead, and current preventive and therapeutic strategies are critical for all health care providers, especially specialists in infectious diseases. An emerging concept is that our residential bacteria, part of human physiology and protective against introduced pathogens, are changing, with important health consequences.
Bacteria have been classified according to phenotype, including size, shape, staining properties, and biochemical properties, since the beginning of microbiology. In recent years classification has been dominated by genotype, especially relying on conserved molecules, such as 16S ribosomal RNA. Although there is a considerable degree of overlap between phenotype and genotype, as would be expected, dichotomies occur. In the future, taxonomy, understanding of pathogenesis, and diagnostics will be increasingly based on genotype and gene expression. Even in resource-limited settings, rapid genotypic identification of drug-resistant M. tuberculosis is close at hand. Proteins expressed under a given condition can be determined by matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry, which generates proteomic mass patterns or fingerprints. As a method for identification of microorganisms, this is rapidly being integrated into the routine analytic pipeline of clinical microbiology laboratories. More advanced “proteotyping” will provide strain-level characterization, including virulence and antibiotic resistance factor expression. Thus physicians and other students of infectious diseases must broaden their knowledge of molecular biology and taxonomy. As bacteriology advances in its differentiation of genera and species, as subspecies diversity is increasingly appreciated, as variation within individual hosts is better understood, and as the evolution of pathogens is better outlined, a grounding in evolutionary biology and ecology also will become more critical. The recent National Institutes of Health Human Microbiome Project already has provided a new scientific basis for the biomedical community toward understanding strain and species variation among the indigenous organisms in human hosts. Over time, this information will be translated into clinical advances in prevention, diagnosis, and treatment of infectious diseases; studies of the human microbiome are already suggesting bacterial roles in diseases that were not previously suspected to have a microbial cause.
Because all organs of the body are subject to bacterial infection, a recitation of these sites would be exhaustive and thus not useful. However, at the least, bacterial infections may be considered as varying in cause, mechanisms, and time frame. Infections may be caused by gram-positive or gram-negative bacilli or cocci; these were the first recognized bacterial agents of disease. However, this simple taxonomy does not fully account for other causative bacterial agents, including Mycobacterium species, treponemes, mycoplasmas, rickettsiae, chlamydiae, and actinomyces, all of which are Eubacteria. Each of these types of organisms has particular stereotypic features that characterize its interactions with hosts, but exceptions and variations abound. In recent years Archaea, a widespread and ancient group of prokaryotes, most closely resembling bacteria, has been isolated from human specimens ; the extent to which they play roles in human diseases is not yet known.
The mechanisms whereby bacteria cause disease are quite varied ( Table 193.1 ). There is no universal mechanism or principle; the causative organism need not even be present in the human body. For example, food poisoning is commonly caused by the ingestion of preformed toxin produced by Clostridium botulinum or Staphylococcus aureus when they are growing in food, not in the host. The scope of bacterial infections includes interactions across time frames that vary from minutes to decades, or longer ( Table 193.2 ). The descendants of the organisms that we each acquire from our mother as a newborn can be the cause of our death in old age (e.g., caused by a perforated diverticulum) to carry the argument to the farthest extreme. Each bacterial infection is unique and reflects the underlying virulence properties of the bacteria and the predisposition of the host. For example, commensals or generally nonpathogenic environmental organisms can cause devastating disease in certain hosts because of genetic inborn errors ; acquired immunodeficiencies from diverse causes, such as human immunodeficiency virus, autoantibodies, or immunomodulatory drugs; or from anatomic defects, such as perforated viscera, indwelling lines, or traumatic injuries. This complexity increases the difficulty in grasping the underlying concepts but also makes the practice of infectious diseases so intellectually satisfying.
MECHANISM | EXAMPLES |
---|---|
Pyogenic infection | Pneumococcal pneumonia, staphylococcal abscess |
Granulomatous infection | Pulmonary tuberculosis, brucellosis, syphilis |
Intoxication (augmentation of host physiology) | Cholera (Vibrio cholerae) |
Intoxication (tissue destruction) | Gas gangrene (Clostridium perfringens), diphtheria (Corynebacterium diphtheriae) |
Immunologic mediation | Guillain-Barré syndrome after Campylobacter jejuni infection; reactive arthritis after shigellosis; acute rheumatic fever after pharyngitis due to Streptococcus pyogenes |
Neoplasia | Adenocarcinoma of the stomach as a consequence of Helicobacter pylori persistence; adenocarcinoma of the esophagus as a consequence of physiologic and microbiologic changes induced by absence of Helicobacter pylori |
TIME FRAME | DISEASE | REPRESENTATIVE CAUSATIVE ORGANISM | CLINICAL MANIFESTATIONS | MECHANISMS |
---|---|---|---|---|
Minutes | Food poisoning | Clostridium perfringens | Vomiting, diarrhea | Preformed enterotoxin |
Hours | Necrotizing fasciitis | Streptococcus pyogenes | Devitalization of muscle, sepsis | Bacterial spread across tissue planes |
Days | Anthrax | Bacillus anthracis | Cough, chest pain, fever, dyspnea | Resistance to macrophage killing |
Weeks | Lung abscess | Oral anaerobes | Cough, fever, chest pain | Necrotizing pyogenic process |
Months | Subacute bacterial endocarditis | α-Hemolytic streptococci | Fever, anemia, stroke, heart failure, uremia | Infection of immunologically privileged site |
Years | Whipple disease | Tropheryma whipplei | Fever, diarrhea, weight loss | Resistance to macrophage killing |
Decades (persistence) | Osteomyelitis | Staphylococcus aureus | Fever, wound discharge, pain | Pyogenic infection of devitalized tissue (±foreign body) |
Decades (latency) | Pulmonary tuberculosis | Mycobacterium tuberculosis | Cough, fever, weight loss | Reactivation of latent focus into active granulomatous process |
Decades (oncogenesis) | Gastric cancer | Helicobacter pylori | Cachexia, abdominal pain | Persistent inflammation leading to progressive metaplastic and dysplastic conditions |
Become a Clinical Tree membership for Full access and enjoy Unlimited articles
If you are a member. Log in here